Akademska digitalna zbirka SLovenije - logo
E-viri
Celotno besedilo
Recenzirano
  • Recombinant or Standard-Dos...
    Hsiao, Amber; Yee, Arnold; Fireman, Bruce; Hansen, John; Lewis, Ned; Klein, Nicola P.

    The New England journal of medicine, 12/2023, Letnik: 389, Številka: 24
    Journal Article

    In a study over two influenza seasons, a high-dose recombinant influenza vaccine was 15% more effective than a standard-dose vaccine in preventing PCR-confirmed influenza in adults between 50 and 64 years of age.